HomeResearch & Knowledgeback to HomeStrategyback to Research & KnowledgeSwisscom ventures digital transformation fund: CVC’S pitch for the futureback to Strategy

Case Study

Swisscom ventures digital transformation fund: CVC’S pitch for the future

By Bettina Büchel, Alejandro Mora Sojo, Alain Nydegger, Klaus Jørgensen and Benjamin Toulouze

20 pages

October 2019

Order this case study

Reference: IMD-7-2089

The case is designed to prompt considerations of the advantages and disadvantages of accepting external money from institutional investors into the corporate venture capital fund (CVC) for Swisscom. Our protagonist Dominique Megret, the head of the CVC, is placed in a situation which exposes him to c-suite pressures which test his ability and conviction to argue his selected path. The historical analysis showed patterns of initial vs follow-up investments, and the strategic horizon of the investments which essentially set out to support Swisscom’s growth intentions. Organic internal options are mentioned as alternatives. As the financial means to continue to invest are limited by Swisscom, the company sets out to find external partners to co-invest – at the time an unusual path towards keeping growth options option. Megret has to convince his board that this is a good option for Swisscom.

Learning Objective

How to articulate the benefit of a CVC.
How to form and present an opinion whether external money should be taken, while considering scenarios, mitigating actions, and long-term impacts to telecommunication companies.
How to best shape a portfolio of investments

Keywords

Strategy, Finance, Corporate Venture Capital, Deal, Exit Strategy, Portfolio Management

Settings

Swisscom, Services, Telecommunications
2007-2018 (Q1)

Type

Field Research

Available Languages

English

Related material

Teaching note

IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Keep reading

Case Study

Oculis: Transforming ophthalmology a drop at a time

Start-up Venture Capital Entrepreneurship Strategy

By Benoit F. Leleux, Abdulaziz A. AlSayyari, Barbara Müller and Vladimir Novotny

Article

South Korea’s Innovation Outputs - Competitiveness

South Korea’s innovation outputs are failing to translate into higher levels of competitiveness. Here’s how other innovation-driven economies can take heed

Competitiveness Geopolitics Strategy

By José Caballero

in I by IMD

Article

Tools for coping in a world in flux

Navigating change has become essential as AI reshapes industries and remote work redefines relationships, forcing leaders and individuals to adapt faster than ever.thank you

Organizational Transformation Strategy

By April Rinne

in I by IMD

Podcast

Inside the transition, with Pictet’s Marie-Laure Schaufelberger

IMD’s Inside the Transition explores how finance drives the energy transition, with Pictet CSO Marie-Laure Schaufelberger on credibility, capital, and ESG.

Finance Leadership Sustainability

By Julia Binder and Knut Haanaes

in I by IMD

Article

What geopolitical maturity looks like

As geopolitics reshapes markets, leading firms move beyond risk mitigation to use foresight, intelligence, and public-private engagement to create competitive advantage.

Geopolitics Strategy

By Simon J. Evenett

in I by IMD

Article

Communication Breakdown - Social Media Signals

A study of 1,000 executive posts shows how using social media signals can boost meaningful engagement by over 300% and redefine effective leadership online.

Leadership Strategy

By Prashant Saxena

in I by IMD

Article

CEO–CFO–Board Triumvirate - Vigilant CFOs

IMD’s Salvatore Cantale explores how CFOs can balance CEO ambition and board oversight to strengthen decision-making and ensure long-term business success.

Board Corporate Governance Finance

By Salvatore Cantale

in I by IMD

Oculis: Transforming ophthalmology a drop at a time

By Benoit F. Leleux Abdulaziz A. AlSayyari Barbara Müller and Vladimir Novotny
Case reference: IMD-2692 ©2025

Summary

For the team at Oculis, the announcement of the new USD 100 million fundraising could not have come at a more opportune moment. The biopharmaceutical startup was founded in 2017 to transform ophthalmology by developing not only original delivery mechanisms but also groundbreaking treatments for eye diseases like Diabetic Macular Edema (DME). Established by seasoned industry experts, Oculis aimed to replace invasive eye treatments with more accessible, patient-friendly solutions such as topical eye drops. The initial research conducted in a laboratory in Iceland led to a pipeline of drug candidates, now at various stages of clinical testing. The firm continued to ramp up thanks to successive rounds of financing from top investors and partners, totaling more than USD 500 million at the end of 2024. However, it also faced some dramatic events, including the sudden death in early 2024 of its CTO. The company continued to scale, strategically balancing clinical advancements with regulatory milestones. The recent secondary offering on Nasdaq would accelerate the clinical development pipeline, in particular its novel neuroprotective candidate Prisosegtor (OCS-05), OCS-01, a topical eye drop for DME, and OCS-02, a topical biologic eye drop candidate for dry eye disease. Oculis now grappled with a number of strategic decisions, with two questions in particular concerning the team. Should it rely mostly on outsourcing production to a contract development and manufacturing organization (CDMO) or develop its own in-house manufacturing capabilities? There were strong benefits and drawbacks to both approaches. It faced a related dilemma with its product pipeline. Should it continue to rely on its own R&D, as in the past, or should it consider acquiring technologies outside, through M&A activities?

Reference IMD-2692

Organization Oculis

Industry Healthcare, Pharmaceuticals

Available Languages English

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Start-up

Venture Capital

Entrepreneurship

Strategy

Browse all topics

South Korea’s Innovation Outputs - Competitiveness

By José Caballero
in I by IMD

Summary

South Korea’s innovation outputs are failing to translate into higher levels of competitiveness. Here’s how other innovation-driven economies can take heed

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Competitiveness

Geopolitics

Strategy

Browse all topics

Inside the transition, with Pictet’s Marie-Laure Schaufelberger

By Julia Binder and Knut Haanaes
in I by IMD

Summary

IMD’s Inside the Transition explores how finance drives the energy transition, with Pictet CSO Marie-Laure Schaufelberger on credibility, capital, and ESG.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Finance

Leadership

Sustainability

Browse all topics

CEO–CFO–Board Triumvirate - Vigilant CFOs

By Salvatore Cantale
in I by IMD

Summary

IMD’s Salvatore Cantale explores how CFOs can balance CEO ambition and board oversight to strengthen decision-making and ensure long-term business success.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Board

Corporate Governance

Finance

Browse all topics